Medicine (RMH) - Research Publications

Permanent URI for this collection

Now showing 1 - 1 of 1

Validation of linear cerebral atrophy markers in multiple sclerosis

Butzkueven, H ; Kolbe, SC ; Jolley, DJ ; Brown, JY ; Cook, MJ ; van der Mei, IAF ; Groom, PS ; Carey, J ; Eckholdt, J ; Rubio, JP ; Taylor, BV ; Mitchell, PJ ; Egan, GF ; Kilpatrick, TJ (ELSEVIER SCI LTD, 2008-02)

Linear measures of cerebral ventricular enlargement may act as surrogate measures of cerebral atrophy in multiple sclerosis (MS). Linear atrophy markers were measured from routine MRI scans during a population survey of 171 Tasmanian MS patients and 91 healthy controls. Thirty-five Victorian MS clinic patients were recruited as a validation cohort with 14 of these re-assessed 4 years later. In the population survey, we measured three linear brain atrophy markers: inter-caudate distance (ICD), third ventricle width (TVW) and frontal horn width (FHW). TVW (OR 2.0, p=0.001) and ICD (OR 16.1, p<0.001) differentiated between MS cases and controls. In the validation study, we correlated the intercaudate ratio (ICR=ICD/brain width) and third ventricular ratio (TVR=TVW/brain width) with brain parenchymal volume. Cross-sectionally, ICR (R=-0.453, p<0.01) and TVR (R=-0.653, p<0.01) were correlated with brain parenchymal volume. Longitudinally, brain parenchymal volume loss was inversely correlated with increased ICD (R=-0.77, p<0.01) and TVW (R=-0.71, p<0.01). This study shows that ICD measurements obtained from clinical MRI scans are valid brain atrophy measures for use in monitoring MS progression.